Cargando…

Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma

BACKGROUND: Matrix metalloproteinase 7 (MMP-7) promotes tumor invasion and metastasis in several cancers. However, its role in lung cancer progression is understudied. In this study, we investigated the correlation between MMP-7 expression and lung cancer pathology. METHODS: We searched the database...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ji-Chang, Li, Xian-Dong, Du, Jin, Xu, Feng, Wei, Yu-Ju, Li, Hong-Bing, Zhang, Yi-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326471/
https://www.ncbi.nlm.nih.gov/pubmed/25588786
http://dx.doi.org/10.1186/1477-7819-13-5
_version_ 1782356937158950912
author Han, Ji-Chang
Li, Xian-Dong
Du, Jin
Xu, Feng
Wei, Yu-Ju
Li, Hong-Bing
Zhang, Yi-Jie
author_facet Han, Ji-Chang
Li, Xian-Dong
Du, Jin
Xu, Feng
Wei, Yu-Ju
Li, Hong-Bing
Zhang, Yi-Jie
author_sort Han, Ji-Chang
collection PubMed
description BACKGROUND: Matrix metalloproteinase 7 (MMP-7) promotes tumor invasion and metastasis in several cancers. However, its role in lung cancer progression is understudied. In this study, we investigated the correlation between MMP-7 expression and lung cancer pathology. METHODS: We searched the databases PubMed, Embase, Web of Science, Cochrane Library, CISCOM, CINAHL, China BioMedicine (CBM) and China National Knowledge Infrastructure (CNKI) for scientific literature relevant to MMP-7 and lung cancer. Carefully selected studies were pooled and ORs with 95% CI were calculated. Subgroup analyses and publication bias were analyzed to understand the retrieved data in greater detail. Version 12.0 STATA software was used for statistical analysis. RESULTS: We retrieved a total of 121 studies through database searches. Finally, 14 cohort studies satisfied our inclusion/exclusion criteria, and these 14 studies, published between 2004 and 2012, were selected for meta-analysis to understand the influence of MMP-7 expression in lung cancer progression. Our results showed consistent differences in MMP-7 expression when comparisons were made between TNM I-II versus III-IV (OR = 1.82, 95% CI: 1.19 to 2.78, P = 0.006); histologic grade 1 to 2 versus 3 to 4 (OR = 1.67, 95% CI: 1.14 to 2.42, P = 0.008); and lymph node-negative versus lymph node-positive samples (OR = 2.81, 95% CI: 1.73 to 4.58, P <0.001), with significantly higher MMP-7 expression levels found in the more advanced stages. Subgroup analysis showed that age was not the factor influencing the associations between histologic grade, LN metastasis and MMP-7 expression in lung cancer patients, as both under 60 and over 60 age groups showed strong correlations (all P <0.05). However, when TNM staging was analyzed for its association with MMP-7 expression, only patients under age 60 showed a statistically significant correlation. CONCLUSIONS: Our meta-analysis results revealed that MMP-7 overexpression is associated with advanced TNM and histological grades, and is linked to aggressive LN metastasis in lung cancer patients; thus MMP-7 is a useful biomarker to assess the disease status in lung cancers.
format Online
Article
Text
id pubmed-4326471
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43264712015-02-14 Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma Han, Ji-Chang Li, Xian-Dong Du, Jin Xu, Feng Wei, Yu-Ju Li, Hong-Bing Zhang, Yi-Jie World J Surg Oncol Research BACKGROUND: Matrix metalloproteinase 7 (MMP-7) promotes tumor invasion and metastasis in several cancers. However, its role in lung cancer progression is understudied. In this study, we investigated the correlation between MMP-7 expression and lung cancer pathology. METHODS: We searched the databases PubMed, Embase, Web of Science, Cochrane Library, CISCOM, CINAHL, China BioMedicine (CBM) and China National Knowledge Infrastructure (CNKI) for scientific literature relevant to MMP-7 and lung cancer. Carefully selected studies were pooled and ORs with 95% CI were calculated. Subgroup analyses and publication bias were analyzed to understand the retrieved data in greater detail. Version 12.0 STATA software was used for statistical analysis. RESULTS: We retrieved a total of 121 studies through database searches. Finally, 14 cohort studies satisfied our inclusion/exclusion criteria, and these 14 studies, published between 2004 and 2012, were selected for meta-analysis to understand the influence of MMP-7 expression in lung cancer progression. Our results showed consistent differences in MMP-7 expression when comparisons were made between TNM I-II versus III-IV (OR = 1.82, 95% CI: 1.19 to 2.78, P = 0.006); histologic grade 1 to 2 versus 3 to 4 (OR = 1.67, 95% CI: 1.14 to 2.42, P = 0.008); and lymph node-negative versus lymph node-positive samples (OR = 2.81, 95% CI: 1.73 to 4.58, P <0.001), with significantly higher MMP-7 expression levels found in the more advanced stages. Subgroup analysis showed that age was not the factor influencing the associations between histologic grade, LN metastasis and MMP-7 expression in lung cancer patients, as both under 60 and over 60 age groups showed strong correlations (all P <0.05). However, when TNM staging was analyzed for its association with MMP-7 expression, only patients under age 60 showed a statistically significant correlation. CONCLUSIONS: Our meta-analysis results revealed that MMP-7 overexpression is associated with advanced TNM and histological grades, and is linked to aggressive LN metastasis in lung cancer patients; thus MMP-7 is a useful biomarker to assess the disease status in lung cancers. BioMed Central 2015-01-14 /pmc/articles/PMC4326471/ /pubmed/25588786 http://dx.doi.org/10.1186/1477-7819-13-5 Text en © Han et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Han, Ji-Chang
Li, Xian-Dong
Du, Jin
Xu, Feng
Wei, Yu-Ju
Li, Hong-Bing
Zhang, Yi-Jie
Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma
title Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma
title_full Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma
title_fullStr Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma
title_full_unstemmed Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma
title_short Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma
title_sort elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326471/
https://www.ncbi.nlm.nih.gov/pubmed/25588786
http://dx.doi.org/10.1186/1477-7819-13-5
work_keys_str_mv AT hanjichang elevatedmatrixmetalloproteinase7expressionpromotesmetastasisinhumanlungcarcinoma
AT lixiandong elevatedmatrixmetalloproteinase7expressionpromotesmetastasisinhumanlungcarcinoma
AT dujin elevatedmatrixmetalloproteinase7expressionpromotesmetastasisinhumanlungcarcinoma
AT xufeng elevatedmatrixmetalloproteinase7expressionpromotesmetastasisinhumanlungcarcinoma
AT weiyuju elevatedmatrixmetalloproteinase7expressionpromotesmetastasisinhumanlungcarcinoma
AT lihongbing elevatedmatrixmetalloproteinase7expressionpromotesmetastasisinhumanlungcarcinoma
AT zhangyijie elevatedmatrixmetalloproteinase7expressionpromotesmetastasisinhumanlungcarcinoma